| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c6eb1154b7f60c152d3936676eb2eca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-34 |
| filingDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772e5ef135d04cb33b19cd40816c364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990c05d51c1e841b59291725d2befb64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f595e97f3aff8bc63baa6aeccc2a77c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3546aae6669ec1a802977deed3266368 |
| publicationDate |
2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104754939-A |
| titleOfInvention |
Methods of treating androgen receptor (AR) positive breast cancer with selective androgen receptor modulators (SARMs) |
| abstract |
The present invention relates to the treatment of androgen receptor positive breast cancer in a subject, such as a female subject. Accordingly, the invention provides methods of: a) treating a subject with breast cancer; b) treating a subject with metastatic breast cancer; c) treating a subject with refractory breast cancer; d) treating e) treating a subject with AR-positive refractory breast cancer; f) treating a subject with AR-positive metastatic breast cancer; g) treating a subject with both AR-positive and ER-positive breast cancer h) treating a subject suffering from triple negative breast cancer; i) treating a subject suffering from advanced breast cancer. |
| priorityDate |
2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |